Senior housing landlords
Stage 3 · Priced inSame shortage, owned through big landlords.
Fear: Pricey at 84 times next year's profits.
Aging population shortage
Occupancy 89.5% and new building at a record low.
More signals means a tighter squeeze. How the signals work.
| BKD Brookdale | Stage 2 · Pulled back | $10.98 Sep 29 | $7.97 – $17.09 | 36% | $19.25 | $175.32 | $85.50 |
| SNDA Sonida | Stage 2 · Pulled back | $37.61 Sep 29 | $24.95 – $44.39 | 15% | $49.50 | $131.61 | $81.25 |
Range bar: the dark tick is the price between the 12-month low (left) and high (right). The green tick is the analysts' average 12-month target, capped at the high. Good case uses that target. Bad case is a 2022-style slump: a 25% market drop scaled by the stock's beta (floor 0.5; 2.5 where beta is missing). Event stocks use an "event fails" estimate. These are what-if numbers, not predictions.
Occupancy 89.5% and new building at a record low.
Stage 2, Pulled back: the shortage is real, but the stocks fell on one specific fear. It scores 4 of 6 shortage signals.
The biggest operator is still unprofitable.
Monthly occupancy data.
Same shortage, owned through big landlords.
Fear: Pricey at 84 times next year's profits.
The FDA says the shortages are over; prices falling.
Fear: Glut.